scholarly journals Antidiabetic and Antilipidemic activity of Poly herbal formulation (PHF) in STZ-NA induced diabetes in rats

2021 ◽  
Vol 12 (3) ◽  
pp. 2239-2247
Author(s):  
Uma P ◽  
Venkatachalam V V ◽  
Mani Chandrika P ◽  
Sorabh Kumar Agrawal

The effects of polyherbal formulations were studied in the streptozotocin-nicotinamide (STZ-NA) induced diabetes rat model. The present study was undertaken to assess the effects of polyherbal formulations on the blood sugar level (BSL) as well as blood lipid level(BLL) of STZ-NA diabetic rats. The leaves of Moringa oleifera and roots of Raphanus raphanistrum were used for the study due to the presence of various phytoconstituents such as alkaloids, saponins, tannins, steroids, phenolic acids, flavonoids. Three polyherbal formulations were prepared from different portions of leaves of Moringa oleifera and roots of Raphanus raphanistrum and titled PHF-I, PHF-II and PHF-III. Diabetes in experimental animals was induced by STZ injection intraperitoneally (i. p) after 30 min of Nicotinamide injection i. p in all animal groups except normal control group animals. Group, I served as normal control received no treatment. Group II served as negative control received streptozotocin-nicotinamide. Group III rats were treated with Metformin, Group IV, Group V and Group VI rats treated with PHF-I, PHF-II and PHF-III respectively. Physical parameters (body weight, feed and water intake), Biochemical parameters (Blood Glucose, Serum Insulin, Serum C-Peptide Level, Serum Leptin, Serum Total cholesterol, Serum Triglycerides, LDL and VLDL) were measured on 0th, 14th and 28th day. The study results and histopathology of the pancreas indicate that oral administration of polyherbal formulation- II proved as a more effective, safe anti-diabetic agent in comparison to Polyherbal formulation I and III by Decrease in body weight, fasting blood glucose, serum glucose level. Increase in serum insulin level, serum C-peptide with a significant decrease in blood serum lipid level.

2020 ◽  
Vol 11 (4) ◽  
pp. 8092-8100
Author(s):  
Uma P ◽  
Venkatachalam V V ◽  
Mani Chandrika P ◽  
Sorabh Kumar Agrawal

The effects of polyherbal formulations were studied in the streptozotocin-nicotinamide (STZ-NA) induced diabetes rat model. The present study was undertaken to assess the effects of polyherbal formulations on the blood sugar level (BSL) as well as blood lipid level(BLL) of STZ-NA diabetic rats. The leaves of Moringa oleifera and roots of Raphanus raphanistrum were used for the study due to the presence of various phytoconstituents such as alkaloids, saponins, tannins, steroids, phenolic acids, flavonoids. Three polyherbal formulations were prepared from different portions of leaves of Moringa oleifera and roots of Raphanus raphanistrum and titled PHF-I, PHF-II and PHF-III. Diabetes in experimental animals was induced by STZ injection intraperitoneally (i. p) after 30 min of Nicotinamide injection i. p in all animal groups except normal control group animals. Group, I served as normal control received no treatment. Group II served as negative control received streptozotocin-nicotinamide. Group III rats were treated with Metformin, Group IV, Group V and Group VI rats treated with PHF-I, PHF-II and PHF-III respectively. Physical parameters (body weight, feed and water intake), Biochemical parameters (Blood Glucose, Serum Insulin, Serum C-Peptide Level, Serum Leptin, Serum Total cholesterol, Serum Triglycerides, LDL and VLDL) were measured on 0th, 14th and 28th day. The study results and histopathology of the pancreas indicate that oral administration of polyherbal formulation- II proved as a more effective, safe anti-diabetic agent in comparison to Polyherbal formulation I and III by Decrease in body weight, fasting blood glucose, serum glucose level. Increase in serum insulin level, serum C-peptide with a significant decrease in blood serum lipid level.


Author(s):  
I. Iwanegbe ◽  
M. Suleiman ◽  
A. Jimah

Aims: To investigate the effect of food blends (plantain, soybean and ginger) on the blood glucose, lipid profile and haematological indices on streptozotocin induced diabetic rats. Methodology: A total of 35 rats of mean body weight 219.07 g separated into7 groups (5 per group) where induced by a single intraperitoneal (I.P) injection of streptozotocin (0.1 g dissolved in 5 ml of freshly prepared sodium citrate buffer 0.1 M, pH 4.5) at a dose of 40 mg/kg body weight after fasting for 12 hours and fed with flours/blends. The flours were produced from plant materials for different treatments/blends (blend A=100% unripe plantain, B=80% unripe plantain, 14% soybean, 6% ginger, C=70% unripe plantain, 26% soybean, 4% ginger, D= 60% unripe plantain, 38% soybean, 2% ginger, E= 50% unripe plantain, 50% soybean) and the phytochemicals and minerals content were determined. Blood glucose was determined at 5 days interval for 25 days. Diabetes was confirmed in rats with blood glucose concentrations >200 mg/dl. After 25 days rats were anaesthetized with chloroform vapour and blood samples collected by cardiac puncture for haematology and lipid profile determination. Results: The results showed that unripe plantain, soya beans and ginger in adequate proportion(C=70% unripe plantain, 26% soybean, 4% ginger or D= 60% unripe plantain, 38% soybean, 2% ginger) could help to reduce blood glucose, improve haematological parameters and lipid profile. Significant reduction was observed in the blood glucose level of rats fed blends C and D from 286 to 85 mg/dl and 307 to 90 mg/dl respectively at the end of experiment. These results also demonstrated that the inclusion of ginger at 6% causes rise in blood glucose level. Total cholesterol (TC) increased in all the blends. However, the lowest concentration of TC was observed in blends C and D. The highest packed cell volume (60%) and Haemoglobin (20 g/dl) level observed in rats fed blend C was significantly higher than the normal control fed conventional feeds. The increase in packed cell volume (PCV) (50%) and Hb (17 g/dl) in diabetic rats demonstrated that the formulated blend C was able to raise PCV and Hb above 50% and 17 g/dl (Normal control NC) respectively. Significant increase (P<0.05) in low density lipoprotein cholesterol (LDLc) was also observed in all the blends with blend C having the least (4.0 mg/dl) close to NC (2.0 mg/dl). Conclusion: From the results it is evident that blend C will manage and improve the health status of diabetic patients.


Author(s):  
Zemene Demelash Kifle ◽  
Agumas Alemu Alehegn ◽  
Baye Yrga Adugna ◽  
Abebe Basazn Mekuria ◽  
Engidaw Fentahun Enyew

Background: Diabetes mellitus is one of the major and common metabolic, and chronic disorders in the world. Several medicinal plants have been used globally for the management of diabetes mellitus. The current study aimed to study the anti-hyperglycemic and anti-hyperlipidemic effects of Bersama abyssinica. Methods: Antidiabetic effect of 80% methanolic crude extract of Bersama abyssinica was studied in repeated dose-treated STZ-induced diabetic mice model. The activities of Bersama abyssinica on serum lipid level and body weight were investigated on STZ-induced diabetic mice. Data were analyzed using one-way ANOVA and significant when the p-value was less than 0.05. Results: All doses of the crude 80% methanolic extract of Bersama abyssinica (100 mg/kg, 200 mg/kg, and 400 mg/kg) exhibited a noticeable BGL reduction when compared with baseline blood glucose level and diabetic control on the 7th and 14th days of administration. Moreover, the higher dose of the extract (at 400 mg/kg) significantly (p < 0.001, 54.3%) decreased the BGL in STZ-induced diabetic mice. The maximum decrement in fasting BGL was achieved at the 14th days: 34.92%, 41.10%, 54.30%, and 59.66%, respectively for BAC 100 mg/kg, BAC 200 mg/kg, BAC 400 mg/kg, and GLC 5 mg/kg treated groups. Bersama abyssinica also displayed a significant (p < 0.05) improvement of serum lipid levels and body weight. Conclusion: Bersama abyssinica crude extract exhibited a significant antidiabetic effect and prevented body weight loss in streptozotocin-induced diabetic mice. The finding also confirmed the valuable biochemical activity of Bersama abyssinica by improving serum lipid levels.


Author(s):  
PULAK MAJUMDER ◽  
PARIDHAVI M

Objective: The concept of the synergistic effect of poly-herbalism was as old as medicine history. Present novel polyherbal formulation (PHF) composed of five different herbs. The present investigation aimed to evaluate the synergistic therapeutic hypoglycemic potential of PHF against streptozotocin (STZ) (60 mg/kg b.w, ip)-induced diabetic rats. Methods: For this therapeutic study, the dose was framed orally once a day to the test objects after STZ dosing at 500 mg/kg/5 ml dosage levels for 21 days. The transformation of body weight and blood glucose level was examined, and the histopathological changes of beta cells of the pancreas, cellular architectures of liver and kidney were also perceived after scarification of the objects. Results: The outcomes were compared to that of glibenclamide (5 mg/kg) treated group. Declines of body weight and blood glucose levels were perceived in STZ-induced diabetic animals very significantly (p<0.01 or p<0.05). However, these diabetic changes were significantly (p<0.01 or p<0.05) decreased in PHF-dosing groups revealed more encouraging effects compared to that of glibenclamide. In the other hand, various liver function and enzymes test (creatinine, urea, total bilirubin, total albumin, alkaline phosphatase, gamma-glutamyl transferase, aspartate transaminases, and alanine transaminases) and lipid profile (total cholesterol, triglycerides, high-density lipoprotein cholesterol, total protein, low-density lipoprotein [LDL], and very LDL) studies strongly indicate the potential action of this novel formulation. Conclusions: It is deliberated that PHF has the favorable effect to normalize the blood glucose levels, and also rejuvenation and reproduction of beta cells lead a better futuristic ant diabetic therapy for diabetic management.


Author(s):  
Pranjal Boruah ◽  
Jashabir Chakraborty ◽  
Suvakanta Dash

Objective: The aim of this study was performed to evaluate Antidiabetic potentiality found in different marketed polyherbal formulation using glucocorticoid-induced hyperglycaemia in the rabbit.Methods: The potentiality of different polyherbal formulation was investigated using dexamethasone (DEX) induced hyperglycaemia in Rabbit. Eight male rabbits were divided into four groups of two each. The first group is regarded as control group received 3 ml of normal saline daily by using the gastric tube for 15 d and remaining three group received (0.35 mg/Kg B.W. single dosage) of dexamethasone tablets which were powdered, dissolved in 3 ml of normal saline daily for 15 d. After 15 d the blood glucose estimated by using a glucometer and it is found that DXE treatment leads to significant increase in levels of glucose and a significant decrease in body weight. After that second group received metformin tablet. The third and fourth group received polyherbal formulation A and formulation B, which are powdered and dissolved in 3 ml of normal saline daily for 15 d at the dose of 0.5 gm/kg body weight orally. After completion of regular administration for 15 d, the blood glucose was again estimated and compare the results of each the group.Conclusion: The Anti-diabetic polyherbal marketed formulations were having less side effect as compared to standard metformin tablet (e. g. body weight loss). And both the polyherbal formulations were found a therapeutic equivalence to each other, also having the approximately similar potentiality to standard metformin tablet.Results: The result was found that the polyherbal marketed formulations were having less side effect as compared to standard metformin tablet (e. g. body weight loss). And both the polyherbal formulations were found significantly decreased in blood glucose level at equal potentiality, which can be consider as therapeutic equivalence to each other, and both the formulation also having the approximately similar potentiality to standard metformin tablet. 


2009 ◽  
Vol 28 (11) ◽  
pp. 679-687
Author(s):  
A. Ismail Khan ◽  
S. Yuvaraj ◽  
E. Suthagar ◽  
C. Parthasarathy ◽  
K. Balasubramanian

Many traditional treatments have been recommended in the alternative system of medicine for diabetes mellitus. However, the mode of action of most of the herbals used has not been defined. It has been reported that sex hormones are important regulators of insulin-mediated events in skeletal muscles. In view of this, a novel herbal preparation containing antidiabetic and aphrodisiac plants was used in the present study. Adult male albino rats were divided into following groups after induction of diabetes. Rats were given an intraperitoneal (i.p.) injection of streptozotocin (STZ), at a dose of 65 mg/kg body weight after overnight fasting, to induce diabetic state with blood glucose levels >250 mg/dL. Group 1—Control rats treated with single i.p. injection of vehicle, Group 2—Rats treated with polyherbal preparation (PHP; 500 mg/kg body weight by oral intubation, morning and evening for 30 days), Group 3—STZ-diabetic rats treated orally with equal volumes of vehicle (water) alone and Group 4—STZ-diabetic rats treated with PHP after 10 days of diabetic induction. STZ-diabetes decreased the body weight, serum insulin level and glucose oxidation in liver and skeletal muscles but increased the fasting blood glucose level. After polyherbal treatment, body weight and glucose oxidation were completely restored to control level while serum insulin level was restored partially and the glucose tolerance was significantly improved. There was a significant decrease in total haemoglobin (Hb) level of diabetic rats when compared to control but polyherbal treatment significantly improved the same. However, the other parameters studied (red blood cell [RBC], white blood corpuscle [WBC], packed cell volume [PCV], mean corpuscular volume [MCV] and mean corpuscular haemoglobin [MCH]) were unaltered. In conclusion, the anti-diabetic properties of PHP appear to be mediated through pancreatic β-cell regeneration, resulting in maintenance of optimal blood glucose and its oxidation in liver and skeletal muscles.


2017 ◽  
pp. 144-151
Author(s):  
TAO SHIHENG

In the present examination, antidiabetic capability of Monothica separates (methanol) has been assessed in alloxan-prompted diabetic hares. Fifteen solid, bunnies were separated into four unique gatherings including, Normal control, Diabetic control , treated with Monothicamethanol remove, with 3 hares in each gathering. The concentrates were given orally for 24 hours, 100 mg, 200 mg, 300 mg extricate per bunny every day. At regular intervals blood test was gathered, serum isolated and absolute glucose level, cholesterol level was controlled by unit strategy. The body weight was recorded on like clockwork interim. The Monothecamethanol extricates lowered blood glucose and cholesterol level demonstrated greatest decrease adequately. The treatment with theseconcentrates additionally diminished the blood glucose and cholesterol. Along these lines, it is presumed that the Monothecapossessnoteworthy antidiabetic movement.


2013 ◽  
Vol 94 (6) ◽  
pp. 915-919 ◽  
Author(s):  
R E Jafarova

Aim. To compare the clinical course of diabetes mellitus induced by alloxan using classic and modified technique. Methods. Experiments were carried out on mature white mongrel rats, which were divided into two groups: the first group (25 rats) was administered a 200 mg/kg single dose of alloxan (classic model), the second group (25 rats) was administered 150 mg/kg of alloxan at the first day, 100 mg/kg of alloxan at the second day and 100 mg/kg of alloxan at the fourth day. 25 intact rats were examined as a control group. The animals were withdrawn from the experiment by decapitation on the 10th and 21st day, blood and tissue samples were taken for the laboratory testing. The animals’ status (mortality, grooming behavior, body weight, food and water intake) were measured by visual examination. The levels of glucose and lipids were assessed using enzyme colorimetric detection («Human» laboratory kits, Germany, FP-901 analyzer), insulin and C-peptide levels were examined by enzyme-linked immunosorbent assay («Chemwell» analyzer, «DEMENITECKILL-WELLSEE» laboratory kits, Germany); levels of diene conjugates and malonic dialdehyde - using the photocolorimetry based on the colored thiobarbituric acid products. Results. In the first group, the mortality reached 68%, mean weight loss - 41.2%. Blood glucose level at the 10th and 21st days was higher by 370.7 и 146.2% respectively compared to intact animals. Insulin level decreased by 95.8 and 83.7%, C-peptide level - by 96 and 83.7%. In the second group, mortality was 32%, mean body weight loss - 36.5%, blood glucose level at the 10th and 21st days elevated by 364.5 and 151.5%, insulin level decreased by 96.1 and 82.9%, C-peptide level - by 96.0 and 83.7% respectively. A moderate hyperlipidemia was observed in both groups with increased levels of cholesterol, triglycerides, low and very-low density lipoproteids, free fatty acids and decreased levels of high density lipoproteids. The concentration of diene conjugates and malonic dialdehyde increased rapidly to a variable degree depending on the tissue anti-oxidative activity. Conclusion. When diabetes mellitus is modeled by the use of alloxan, an acute form of alloxan-induced diabetes is observed on the 10th day, a chronic form - on the 21st day in both groups. The modified model of alloxan-induced diabetes showed 36% less mortality rate compared to the classic model.


2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 345-345
Author(s):  
Kate Ormiston ◽  
Zihan Zhang ◽  
Kelly Murphy ◽  
A Courtney DeVries ◽  
Maryam Lustberg ◽  
...  

Abstract Objectives Our objective was to examine effects of dietary enrichment of eicosapentaenoic acid + docosahexaenoic acid (EPA + DHA) on high fat diet-induced insulin resistance during chemotherapy. Methods Adult, female C57Bl/6 mice (n = 48) were assigned to 1 of 3 diets; low-fat diet (LF; 10% kcals fat), high-fat diet (HF; 45% kcals fat), or HF diet with omega-3 s (HF n-3; 2% kcals EPA + DHA) for 7 weeks. Mice received vehicle or chemotherapy injections (doxorubicin + cyclophosphamide), by tail vein at week 4 and 6. Food intake and body weights were recorded. Fasted blood glucose and serum insulin were measured weekly.  Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. Body composition was measured using Echo MRI. Data were analyzed using ANOVA; p &lt; 0.05 was considered significant. Results Total kilocalories significantly differed by group (p &lt; 0.001); HF and HF n-3 groups consumed more than the LF group (p &lt; 0.001, p &lt; 0.0001; respectively). Obesity was induced prior to first injection with body weights being significantly different (p &lt; 0.01); the LF group weighed less than the HF n-3 group (p &lt; 0.01), and there was a similar trend between LF and HF groups (p = 0.0519). Body weights at sacrifice significantly differed (p &lt; 0.0001); chemotherapy mice weighed less than vehicle (p &lt; 0.0001). Percent body fat at sacrifice significantly differed (p &lt; 0.0001); chemotherapy mice had less fat than vehicle (p &lt; 0.0001), and the LF group had less fat than HF  (p &lt; 0.01) and HF n-3 group (p &lt; 0.01). Blood glucose significantly differed at sacrifice (p &lt; 0.01); chemotherapy mice had lower glucose than vehicle (p &lt; 0.05) and HF group had higher glucose than LF group (p &lt; 0.01). HOMA-IR scores at sacrifice significantly differed (p &lt; 0.05); chemotherapy mice had lower scores than vehicle  (p &lt; 0.05) and mice on the LF and HF n-3 diets had lower scores than the HF diet (p &lt; 0.01; p &lt; 0.05 respectively). Conclusions Chemotherapy lowered body weight and body fat in mice, potentially contributing to decreases in blood glucose and insulin resistance. EPA + DHA enrichment of a HF diet reduced insulin resistance in mice comparable to a LF diet group. This occurred in both chemotherapy and vehicle treated mice, despite LF diet-fed mice having lower body weight and adiposity. Underlying mechanisms are being investigated. Funding Sources NIH #5R01CA18994.


Sign in / Sign up

Export Citation Format

Share Document